The Memphis Business Group on Health (MBGH) is pleased to make this forum, including all web pages and web sites accessed from this page, available to Web Site users and others. However, the MBGH does not render legal or consultation services, and legal counsel must be consulted to determine any material’s applicability to any specific situation. MBGH cannot warrant or control the quality, accuracy, or validity of the information posted here. Comments posted on this blog are the sole responsibility of their writers. Use of such information is at the risk of the accessing user and the accessing user assumes all liabilities that may result from such use.




Patients Overpay for Prescriptions 23% of the Time

A new study  released by the University of Southern California found that the 1.9 million people that filled 9.5 million prescriptions in the first 6 months of 2013 overpaid for those prescriptions 23% of the time for a total of $135 million in overpayments. Turns out, their copay was higher than the full cost of the drug. Referred to as a "clawback", the middlemen that handle drug claims essentially "claw back" the difference between the higher copay and the lower... Read More
Posted by Cristie Travis at Tuesday, March 27, 2018

Unpacking Spending Growth

On March 13, 2018, the pronouncement was made that in 2016 price, once again, was the major reason the U.S. spends twice as much on health care as other developed countries (JAMA.2018;319(10):1024-1039).  At the end of their article the authors frame this a health policy issue: “As patients, physicians, policy makers, and legislators debate the future of the health care system, data such as these are needed to inform policy decisions.” Categorizing U.S. health... Read More
Posted by Cristie Travis at Sunday, March 25, 2018

From Our Blog

Say Hello

Please feel free to drop us a line via the button below. We try to respond to every email we receive.

Stay Connected

Join the MBGH community and keep up to date with issues concerning Memphis healthcare.

Facebook Twitter LinkedIn Feed